| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/24/2011 | WO2011034809A1 Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin |
| 03/24/2011 | WO2011034798A1 Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes |
| 03/24/2011 | WO2011034723A1 Improved device and method for delivery of a medicament |
| 03/24/2011 | WO2011034644A1 Heat resistant delivery system |
| 03/24/2011 | WO2011034604A2 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 03/24/2011 | WO2011034554A1 A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti -inflammatory drug |
| 03/24/2011 | WO2011034551A2 Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
| 03/24/2011 | WO2011034513A1 The granules with improved solubility and stability |
| 03/24/2011 | WO2011034465A1 A pharmaceutical composition for peroral administration of diindolylmethane |
| 03/24/2011 | WO2011034462A1 Combined anti-tuberculosis preparation |
| 03/24/2011 | WO2011034396A2 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 03/24/2011 | WO2011034394A2 Oxaliplatin nanoparticles and method for preparing same |
| 03/24/2011 | WO2011034323A2 Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
| 03/24/2011 | WO2011034274A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol |
| 03/24/2011 | WO2011034207A1 Partial peptide of lacritin |
| 03/24/2011 | WO2011034192A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin |
| 03/24/2011 | WO2011034131A1 Agent for the prevention or treatment of inflammatory bowel disease |
| 03/24/2011 | WO2011034105A1 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 03/24/2011 | WO2011033509A1 Devices, systems and methods for quantifying bolus doses according to user parameters |
| 03/24/2011 | WO2011033310A1 Encapsulated intestinal flora extracted from feces for use in the treatment of gastrointestinal disorders |
| 03/24/2011 | WO2011033306A1 Inhibition of tendon adhesions |
| 03/24/2011 | WO2011033085A1 Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers |
| 03/24/2011 | WO2011033024A1 Controlled release composition comprising levetiracetam |
| 03/24/2011 | WO2011033019A1 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin |
| 03/24/2011 | WO2011032992A2 Process for dewatering of product powders and pharmaceuticals compositions produced according to this process |
| 03/24/2011 | WO2011032929A1 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability |
| 03/24/2011 | WO2011032916A1 Pellets coated with coatings containing active substances |
| 03/24/2011 | WO2011032907A1 Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants |
| 03/24/2011 | WO2011032896A2 Encapsulation using wax-type substances |
| 03/24/2011 | WO2011032882A1 Orally disintegrating pharmaceutical dosage form containing aripiprazole |
| 03/24/2011 | WO2011032860A1 Method for producing preparations of substances with low solubility in water |
| 03/24/2011 | WO2011032563A1 Medical use of spla2 hydrolysable liposomes |
| 03/24/2011 | WO2011032416A1 Pharmaceutical composition containing dopamine receptor agonist |
| 03/24/2011 | WO2011032386A1 Osmotic pump controlled release tablet and preparation method thereof |
| 03/24/2011 | WO2011032318A1 Stable artesunate-amodiaquine hydrochloride complex tablet and preparation method thereof |
| 03/24/2011 | WO2011032203A1 Contact lens disinfecting solutions |
| 03/24/2011 | WO2011013130A3 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 03/24/2011 | WO2011012867A4 A delivery system comprising a silicon-containing material |
| 03/24/2011 | WO2010149980A3 Topical formulation containing a tetracycline and a method of treating skin infections using the same |
| 03/24/2011 | WO2010149363A3 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis |
| 03/24/2011 | WO2010148007A9 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 03/24/2011 | WO2010132562A3 Transdermal delivery of metformin |
| 03/24/2011 | WO2010129545A3 Porous silicon drug-eluting particles |
| 03/24/2011 | WO2010122358A3 Chewable oral delivery system |
| 03/24/2011 | WO2010120892A3 Improved oral drug devices and drug formulations |
| 03/24/2011 | WO2010119300A3 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |
| 03/24/2011 | WO2010118200A3 Liposomal formulations of tocopheryl amides |
| 03/24/2011 | WO2010111652A3 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 03/24/2011 | WO2010111178A4 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 03/24/2011 | WO2010099552A8 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| 03/24/2011 | WO2010092597A3 Liposomal citicoline injection |
| 03/24/2011 | WO2010010555A8 Transdermal system for extended delivery of incretins and incretin mimetic peptides |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071203 Transmucosal veterinary composition comprising detomidine |
| 03/24/2011 | US20110071186 Organic compounds |
| 03/24/2011 | US20110071181 Effervescent oral opiate dosage forms and methods of administering opiates |
| 03/24/2011 | US20110071137 Process for preparing sustained release tablets |
| 03/24/2011 | US20110071118 Methods of Making Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastointestinal Tract and Providing Enhanced Therapeuitc Activity |
| 03/24/2011 | US20110070311 Producing a sustained-release preparation |
| 03/24/2011 | US20110070310 Topical ophthalmic pharmaceutical formulation of (2s,3s,4r)-n''-cyano-n-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2h-benzopyran-4-yl)-n'-benzylguanidine |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070308 Bed bug insecticide |
| 03/24/2011 | US20110070307 Tissue regeneration |
| 03/24/2011 | US20110070306 Antimicrobial nanoemulsion compositions and methods |
| 03/24/2011 | US20110070305 Sustained release pharmaceutical composition containing mebicar |
| 03/24/2011 | US20110070304 Manufacture of tablet having immediate release region and sustained release region |
| 03/24/2011 | US20110070303 Novel dosage formulation |
| 03/24/2011 | US20110070302 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 03/24/2011 | US20110070301 Orally transformable tablets |
| 03/24/2011 | US20110070300 Extended release dosage forms of metoprolol |
| 03/24/2011 | US20110070299 Delayed release pharmaceutical composition of duloxetine |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070297 Glucokinase activators |
| 03/24/2011 | US20110070296 Topical compositions and methods for utilizing peptides containing lipid-modified cysteine-containing peptides |
| 03/24/2011 | US20110070295 Methods for the preparation of liposomes comprising docetaxel |
| 03/24/2011 | US20110070294 Methods for the Administration of Drugs Using Liposomes |
| 03/24/2011 | US20110070293 Methods for the Preparation of Liposomes Comprising Docetaxel |
| 03/24/2011 | US20110070292 Methods For The Preparation Of Liposomes |
| 03/24/2011 | US20110070291 Food or beverage composition fortified with thyronamines and/or thyronamine precursors |
| 03/24/2011 | US20110070290 Vaccine composition containing synthetic adjuvant |
| 03/24/2011 | US20110070289 Adaptable modified virus vector to deliver modified messenger ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient diseases |
| 03/24/2011 | US20110070288 Composite layered hemostasis device |
| 03/24/2011 | US20110070287 Film-Coated Compressed Chewing Gum |
| 03/24/2011 | US20110070286 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 03/24/2011 | US20110070285 Method of making flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time |
| 03/24/2011 | US20110070284 Biologic matrices comprising anti-infective methods and compositions related thereto |
| 03/24/2011 | US20110070276 Bioactive keratin peptides |
| 03/24/2011 | US20110070275 Crystalline pyrithione/zinc oxide composite and physiologic/antibiotic composition containing the same |
| 03/24/2011 | US20110070272 Materials and Methods for Modulating Metabolism |
| 03/24/2011 | US20110070271 Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| 03/24/2011 | US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN |
| 03/24/2011 | US20110070231 Stable liquid pharmaceutical formulation of igg antibodies |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | US20110070213 Dermal compositions containing coenzyme q as the active ingredient |
| 03/24/2011 | US20110070176 Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
| 03/24/2011 | US20110070170 Manufacture of chewing gum product with radiofrequency |
| 03/24/2011 | US20110070169 Effervescent Oral Fentanyl Dosage Form and Methods of Administering Fentanyl |
| 03/24/2011 | US20110070168 Macrocyclic peptides as inhibitors of viral replication |